Literature DB >> 25603899

Common single nucleotide variants underlying drug addiction: more than a decade of research.

Kora-Mareen Bühler1, Elena Giné2, Victor Echeverry-Alzate1, Javier Calleja-Conde1, Fernando Rodriguez de Fonseca3, Jose Antonio López-Moreno1.   

Abstract

Drug-related phenotypes are common complex and highly heritable traits. In the last few years, candidate gene (CGAS) and genome-wide association studies (GWAS) have identified a huge number of single nucleotide polymorphisms (SNPs) associated with drug use, abuse or dependence, mainly related to alcohol or nicotine. Nevertheless, few of these associations have been replicated in independent studies. The aim of this study was to provide a review of the SNPs that have been most significantly associated with alcohol-, nicotine-, cannabis- and cocaine-related phenotypes in humans between the years of 2000 and 2012. To this end, we selected CGAS, GWAS, family-based association and case-only studies published in peer-reviewed international scientific journals (using the PubMed/MEDLINE and Addiction GWAS Resource databases) in which a significant association was reported. A total of 371 studies fit the search criteria. We then filtered SNPs with at least one replication study and performed meta-analysis of the significance of the associations. SNPs in the alcohol metabolizing genes, in the cholinergic gene cluster CHRNA5-CHRNA3-CHRNB4, and in the DRD2 and ANNK1 genes, are, to date, the most replicated and significant gene variants associated with alcohol- and nicotine-related phenotypes. In the case of cannabis and cocaine, a far fewer number of studies and replications have been reported, indicating either a need for further investigation or that the genetics of cannabis/cocaine addiction are more elusive. This review brings a global state-of-the-art vision of the behavioral genetics of addiction and collaborates on formulation of new hypothesis to guide future work.
© 2015 Society for the Study of Addiction.

Entities:  

Keywords:  Candidate gene association studies; GWAS; drug addiction; single nucleotide polymorphisms

Mesh:

Year:  2015        PMID: 25603899     DOI: 10.1111/adb.12204

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  35 in total

1.  Genetic variation in FAAH is associated with cannabis use disorders in a young adult sample of Mexican Americans.

Authors:  Whitney E Melroy-Greif; Kirk C Wilhelmsen; Cindy L Ehlers
Journal:  Drug Alcohol Depend       Date:  2016-06-25       Impact factor: 4.492

2.  Differential potassium channel gene regulation in BXD mice reveals novel targets for pharmacogenetic therapies to reduce heavy alcohol drinking.

Authors:  Jennifer A Rinker; Diana B Fulmer; Heather Trantham-Davidson; Maren L Smith; Robert W Williams; Marcelo F Lopez; Patrick K Randall; L Judson Chandler; Michael F Miles; Howard C Becker; Patrick J Mulholland
Journal:  Alcohol       Date:  2016-06-27       Impact factor: 2.405

Review 3.  Seeing through the smoke: Human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks.

Authors:  Mason M Silveira; Jonathon C Arnold; Steven R Laviolette; Cecilia J Hillard; Marta Celorrio; María S Aymerich; Wendy K Adams
Journal:  Neurosci Biobehav Rev       Date:  2016-09-14       Impact factor: 8.989

4.  Deep Sequencing of 71 Candidate Genes to Characterize Variation Associated with Alcohol Dependence.

Authors:  Shaunna L Clark; Joseph L McClay; Daniel E Adkins; Gaurav Kumar; Karolina A Aberg; Srilaxmi Nerella; Linying Xie; Ann L Collins; James J Crowley; Corey R Quackenbush; Christopher E Hilliard; Andrey A Shabalin; Scott I Vrieze; Roseann E Peterson; William E Copeland; Judy L Silberg; Matt McGue; Hermine Maes; William G Iacono; Patrick F Sullivan; Elizabeth J Costello; Edwin J van den Oord
Journal:  Alcohol Clin Exp Res       Date:  2017-03-24       Impact factor: 3.455

Review 5.  Promising pharmacogenetic targets for treating alcohol use disorder: evidence from preclinical models.

Authors:  Jennifer A Rinker; Patrick J Mulholland
Journal:  Pharmacogenomics       Date:  2017-03-27       Impact factor: 2.533

Review 6.  ADH1B: From alcoholism, natural selection, and cancer to the human phenome.

Authors:  Renato Polimanti; Joel Gelernter
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2017-03-27       Impact factor: 3.568

7.  Knockout of alpha 5 nicotinic acetylcholine receptors subunit alters ethanol-mediated behavioral effects and reward in mice.

Authors:  Anton Dawson; Jennifer T Wolstenholme; Monzurul A Roni; Vera C Campbell; Asti Jackson; Cassandra Slater; Deniz Bagdas; Erika E Perez; Jill C Bettinger; Mariella De Biasi; Michael F Miles; M Imad Damaj
Journal:  Neuropharmacology       Date:  2018-06-23       Impact factor: 5.250

8.  Connecting the dots, genome-wide association studies in substance use.

Authors:  M G Nivard; K J H Verweij; C C Minică; J L Treur; J M Vink; D I Boomsma
Journal:  Mol Psychiatry       Date:  2016-03-15       Impact factor: 15.992

Review 9.  Nicotinic acetylcholine receptors and nicotine addiction: A brief introduction.

Authors:  Ruthie E Wittenberg; Shannon L Wolfman; Mariella De Biasi; John A Dani
Journal:  Neuropharmacology       Date:  2020-07-29       Impact factor: 5.250

10.  Short-Term Genetic Selection for Adolescent Locomotor Sensitivity to Delta9-Tetrahydrocannabinol (THC).

Authors:  Chelsea R Kasten; Yanping Zhang; Ken Mackie; Stephen L Boehm
Journal:  Behav Genet       Date:  2018-03-17       Impact factor: 2.805

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.